FDA approves Pfizer maternal RSV vaccine for infants
August 21, 2023 at 17:43 PM EDT
Pfizer hopes that its respiratory syncytial virus vaccine will be available to the public by the end of October or the beginning of November.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.